These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 30703749)
41. Intra-individual correlations between quantitative THK-5351 PET and MRI-derived cortical volume in Alzheimer's disease differ according to disease severity and amyloid positivity. Park JE; Yun J; Kim SJ; Shim WH; Oh JS; Oh M; Roh JH; Seo SW; Oh SJ; Kim JS PLoS One; 2019; 14(12):e0226265. PubMed ID: 31834916 [TBL] [Abstract][Full Text] [Related]
42. Loss of clusterin shifts amyloid deposition to the cerebrovasculature via disruption of perivascular drainage pathways. Wojtas AM; Kang SS; Olley BM; Gatherer M; Shinohara M; Lozano PA; Liu CC; Kurti A; Baker KE; Dickson DW; Yue M; Petrucelli L; Bu G; Carare RO; Fryer JD Proc Natl Acad Sci U S A; 2017 Aug; 114(33):E6962-E6971. PubMed ID: 28701379 [TBL] [Abstract][Full Text] [Related]
43. Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer's disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database. Ben Bouallègue F; Mariano-Goulart D; Payoux P; Alzheimers Res Ther; 2017 Apr; 9(1):32. PubMed ID: 28441967 [TBL] [Abstract][Full Text] [Related]
44. Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees. Klunk WE; Price JC; Mathis CA; Tsopelas ND; Lopresti BJ; Ziolko SK; Bi W; Hoge JA; Cohen AD; Ikonomovic MD; Saxton JA; Snitz BE; Pollen DA; Moonis M; Lippa CF; Swearer JM; Johnson KA; Rentz DM; Fischman AJ; Aizenstein HJ; DeKosky ST J Neurosci; 2007 Jun; 27(23):6174-84. PubMed ID: 17553989 [TBL] [Abstract][Full Text] [Related]
45. A second pedigree with amyloid-less familial Alzheimer's disease harboring an identical mutation in the amyloid precursor protein gene (E693delta). Kutoku Y; Ohsawa Y; Kuwano R; Ikeuchi T; Inoue H; Ataka S; Shimada H; Mori H; Sunada Y Intern Med; 2015; 54(2):205-8. PubMed ID: 25743013 [TBL] [Abstract][Full Text] [Related]
46. Imaging of amyloid burden and distribution in cerebral amyloid angiopathy. Johnson KA; Gregas M; Becker JA; Kinnecom C; Salat DH; Moran EK; Smith EE; Rosand J; Rentz DM; Klunk WE; Mathis CA; Price JC; Dekosky ST; Fischman AJ; Greenberg SM Ann Neurol; 2007 Sep; 62(3):229-34. PubMed ID: 17683091 [TBL] [Abstract][Full Text] [Related]
47. Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and Ottoy J; Niemantsverdriet E; Verhaeghe J; De Roeck E; Struyfs H; Somers C; Wyffels L; Ceyssens S; Van Mossevelde S; Van den Bossche T; Van Broeckhoven C; Ribbens A; Bjerke M; Stroobants S; Engelborghs S; Staelens S Neuroimage Clin; 2019; 22():101771. PubMed ID: 30927601 [TBL] [Abstract][Full Text] [Related]
48. APP Mutations in Cerebral Amyloid Angiopathy with or without Cortical Calcifications: Report of Three Families and a Literature Review. Sellal F; Wallon D; Martinez-Almoyna L; Marelli C; Dhar A; Oesterlé H; Rovelet-Lecrux A; Rousseau S; Kourkoulis CE; Rosand J; DiPucchio ZY; Frosch M; Gombert C; Audoin B; Miné M; Riant F; Frebourg T; Hannequin D; Campion D; Greenberg SM; Tournier-Lasserve E; Nicolas G J Alzheimers Dis; 2017; 56(1):37-46. PubMed ID: 27858710 [TBL] [Abstract][Full Text] [Related]
50. Beta A4 protein deposition in familial Alzheimer's disease with the mutation in codon 717 of the beta A4 amyloid precursor protein gene and sporadic Alzheimer's disease. Cairns NJ; Chadwick A; Lantos PL; Levy R; Rossor MN Neurosci Lett; 1993 Jan; 149(2):137-40. PubMed ID: 8474686 [TBL] [Abstract][Full Text] [Related]
51. Alzheimer dementia caused by a novel mutation located in the APP C-terminal intracytosolic fragment. Theuns J; Marjaux E; Vandenbulcke M; Van Laere K; Kumar-Singh S; Bormans G; Brouwers N; Van den Broeck M; Vennekens K; Corsmit E; Cruts M; De Strooper B; Van Broeckhoven C; Vandenberghe R Hum Mutat; 2006 Sep; 27(9):888-96. PubMed ID: 16917905 [TBL] [Abstract][Full Text] [Related]
52. Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study. Gordon BA; Blazey TM; Su Y; Hari-Raj A; Dincer A; Flores S; Christensen J; McDade E; Wang G; Xiong C; Cairns NJ; Hassenstab J; Marcus DS; Fagan AM; Jack CR; Hornbeck RC; Paumier KL; Ances BM; Berman SB; Brickman AM; Cash DM; Chhatwal JP; Correia S; Förster S; Fox NC; Graff-Radford NR; la Fougère C; Levin J; Masters CL; Rossor MN; Salloway S; Saykin AJ; Schofield PR; Thompson PM; Weiner MM; Holtzman DM; Raichle ME; Morris JC; Bateman RJ; Benzinger TLS Lancet Neurol; 2018 Mar; 17(3):241-250. PubMed ID: 29397305 [TBL] [Abstract][Full Text] [Related]
53. Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection. Ikonomovic MD; Buckley CJ; Heurling K; Sherwin P; Jones PA; Zanette M; Mathis CA; Klunk WE; Chakrabarty A; Ironside J; Ismail A; Smith C; Thal DR; Beach TG; Farrar G; Smith AP Acta Neuropathol Commun; 2016 Dec; 4(1):130. PubMed ID: 27955679 [TBL] [Abstract][Full Text] [Related]